<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr82-1759720X20912646">
 <label>82</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Winthrop</surname>
    <given-names>KL</given-names>
   </name>
   <name>
    <surname>Mariette</surname>
    <given-names>X</given-names>
   </name>
   <name>
    <surname>Silva</surname>
    <given-names>JT</given-names>
   </name>
  </person-group>, 
  <etal>et al</etal>
  <article-title>ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunoglobuli</article-title>. 
  <source>Clin Microbiol Infect</source>
  <year>2018</year>; 
  <volume>24</volume>: 
  <fpage>S21</fpage>â€“
  <lpage>S40</lpage>.
  <pub-id pub-id-type="pmid">29447987</pub-id>
 </mixed-citation>
</ref>
